Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sujay Rainchwar
Observed names:
Rainchwar Sujay,
Rainchwar, Sujay
Institution:
Rajiv Gandhi Cancer Institute and Research Centre
Observed institutions:
Northwestern University,
Rajiv Gandhi Cancer Institute and Research Centre,
Medical University of Lodz,
Robert H. Lurie Comprehensive Cancer Center of Northwestern University,
All India Institute of Medical Sciences
ORCID:
0000-0003-3040-5968
Observed ORCID:
0000-0003-3040-5968
OpenAlex ID:
A5010748649
Pneumocystis jirovecii pneumonia [PJP]: An unrecognized concern in AML patients on Venetoclax
2022
·
Sujay Rainchwar
, Rohan Halder
, et al.
·
Leukemia Research
·
7
Evaluating Health-Related Quality of Life in Thalassemia: Low-Dose Thalidomide vs. Standard Care—Insights from a Comparative Study
2025
·
Varsha Mishra
, Pratibha Singh Yadav
, et al.
·
Hemoglobin
·
3
Response Adapted Dasatinib De-Escalation Strategy Compared to Upfront Low-Dose Dasatinib: A Prospective Cohort Study
2024
·
Reema Singh
, Sujay Rainchwar
, et al.
·
Blood
·
3
PDF
Real World Outcome of High-Risk Multiple Myeloma: An Indian Tertiary Care Centre Experience
2024
·
Anveshika Soni
, Sujay Rainchwar
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
·
3
Low fixed dose pembrolizumab with gemcitabine, vinorelbine, liposomal doxorubicin (Pembro100 -GVD) as an effective salvage regimen in relapsed refractory classical hodgkin’s lymphoma and primary mediastinal B cell lymphoma
2023
·
Tribikram Panda
, Sujay Rainchwar
, et al.
·
Annals of Hematology
·
3
Response-adapted dasatinib de-escalation strategy compared to upfront Low-dose dasatinib: A prospective cohort study
2026
·
Rohan Halder
, Reema Singh
, et al.
·
Leukemia Research
·
2
Allogeneic transplantation for CML blast phase: Learnings over last decade from a single centre in North India
2025
·
Pritish Chandra Patra
, Sujay Rainchwar
, et al.
·
Annals of Hematology
·
2
PDF
Real world outcome of B ALL with t (1; 19) (q23; p13)/TCF3::PBX1 in adolescents and adults treated with intensive regimes
2024
·
Tribikram Panda
, Sujay Rainchwar
, et al.
·
Leukemia Research
·
2
Matched Unrelated Donor (MUD) Hematopoietic Stem Cell Transplant in Thalassemia Patient: An Outcome-Based Analysis of Pediatric Cohort in Tertiary Cancer Care Centre of North India
2024
·
Reema Singh
, Mayank Soni
, et al.
·
Transplantation and Cellular Therapy
·
1
ALL-215 Improved Outcomes of Acute Lymphoblastic Leukemia (ALL) in Adolescent and Young Adults (AYA) Treated With Modified COG0232, a Paediatric-Inspired Intensive Regimen
2023
·
Sujay Rainchwar
, Tribikram Panda
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
·
1
HIV Associated Lymphomas: A Double-Edged Sword
2023
·
Reema Singh
, Jyotsna Kapoor
, et al.
·
Indian Journal of Hematology and Blood Transfusion
·
1
PDF
AML-949: Upfront Triple Therapy With FLAG-Venetoclax Backbone in Intensive Chemotherapy-Eligible FLT3-ITD Patients With AML: Preliminary Results From a Retrospective Cohort
2026
·
Mayank Soni
, Rohan Halder
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
HL-789: First-Line Treatment Patterns and Outcomes in Older Patients With Hodgkin Lymphoma in a Resource-Limited Setting: A Real-World Retrospective Single-Center Study
2026
·
Vijaya Moorthy Giri Raja Pandian
, Sujay Rainchwar
·
Clinical Lymphoma Myeloma & Leukemia
POSTER: CML-1655: Superior 96-Week MMR Rates and Safety With Generic Dasatinib 50 mg in Newly Diagnosed CML: Large Real-World Multicenter Study From India
2026
·
Sujay Rainchwar
, Rohan Halder
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
CML-426: Efficacy and Safety of Asciminib as Second-Line or Later Therapy in Chronic-Phase Chronic Myeloid Leukemia: An Updated Systematic Review and Meta-Analysis
2026
·
Shivam Rainchwar
, Riya Patil
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
MDS-433: When International Normalized Ratio Deceives: Pharmacogenetic Warfarin Failure in Antiphospholipid Syndrome
2026
·
Shivam Rainchwar
, Vijaya Moorthy
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
POSTER: HL-789: First-Line Treatment Patterns and Outcomes in Older Patients With Hodgkin Lymphoma in a Resource-Limited Setting: A Real-World Retrospective Single-Center Study
2026
·
Vijaya Moorthy Giri Raja Pandian
, Sujay Rainchwar
·
Clinical Lymphoma Myeloma & Leukemia
POSTER: CML-426: Efficacy and Safety of Asciminib as Second-Line or Later Therapy in Chronic-Phase Chronic Myeloid Leukemia: An Updated Systematic Review and Meta-Analysis
2026
·
Shivam Rainchwar
, Riya Patil
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
MM-463: Teclistamab Therapy for Relapsed/Refractory Multiple Myeloma With High Disease Burden: Experience From an LMIC Community-Based Non-ICU Setting
2026
·
Shivam Rainchwar
, Gautam Makadia
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
POSTER: AML-949: Upfront Triple Therapy With FLAG-Venetoclax Backbone in Intensive Chemotherapy-Eligible FLT3-ITD Patients With AML: Preliminary Results From a Retrospective Cohort
2026
·
Mayank Soni
, Rohan Halder
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
CML-1655: Superior 96-Week MMR Rates and Safety With Generic Dasatinib 50 mg in Newly Diagnosed CML: Large Real-World Multicenter Study From India
2026
·
Sujay Rainchwar
, Rohan Halder
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
MM-673: Efficacy and Safety of Teclistamab in Extramedullary Relapsed/Refractory Multiple Myeloma: A Systematic Review and Meta-Analysis
2026
·
Shivam Rainchwar
, Himanshu Lanje
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
MDS-928: Adult-Onset Presentation of Congenital Sideroblastic Anemia Associated With Novel Missense Variant Initially Misdiagnosed as MDSRS
2026
·
Shivam Rainchwar
, Alpesh Kikani
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
CML-1600: Improving Outcomes in Chronic Myeloid Leukemia With Early Switch to Second-Generation Generic Tyrosine Kinase Inhibitors: A Study From Resource-Limited Settings in Western India
2026
·
Reema Singh
, Sujay Rainchwar
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
POSTER: MM-673: Efficacy and Safety of Teclistamab in Extramedullary Relapsed/Refractory Multiple Myeloma: A Systematic Review and Meta-Analysis
2026
·
Shivam Rainchwar
, Himanshu Lanje
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Show more works
View as search
Works count:
51
Citation count:
28
H-index:
3
I10-index:
Year
Topic
Type